Absolute Bioavailability and ADME Study of [14C]AZD9977 in Healthy Male Subjects

NCT04686591 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Disease

Interventions

DRUG: AZD9977 capsule 50 mg
DRUG: [14C]AZD9977 Solution for Infusion, 20 µg/mL (NMT 37.0 kBq/5 mL)
DRUG: [14C]AZD9977 Oral Suspension, 100 mg (NMT 9.9 MBq)

Sponsor

AstraZeneca

Collaborators

[object Object]